Tetsudo Kaya

This inventor holds 4 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Japan Tobacco Inc.. Active years: 2000-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tetsudo Kaya. Retrieved from https://idiyas.com/inventor/tetsudo-kaya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 (Patent Applications = 6)

% Patents Active = 50.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 3.5

ph-index = 3

Forward Citations = 62(Granted Patents)

Company Filing History:

4 out of 1,068

Japan Tobacco Inc.

patents

Years Active: 2000-2012

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8299070 - Indole compounds and pharmaceutical use thereof (2012-10-30),

2. 6806276 - 2-oxoquinoline compounds and pharmaceutical uses thereof (2004-10-19),

3. 6509352 - 2-oxoquinoline compounds and medicinal uses thereof (2003-01-21),

4. 6017919 - Compounds and pharmaceutical use thereof (2000-01-25),

Title: Tetsudo Kaya: Innovator in Pharmaceutical Compounds

Introduction

Tetsudo Kaya is a prominent inventor based in Takatsuki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds for treating various diseases. With a total of 4 patents to his name, Kaya's work is recognized for its potential impact on healthcare.

Latest Patents

Kaya's latest patents include groundbreaking research on indole compounds and their pharmaceutical uses. This patent provides an agent for the treatment or prophylaxis of inflammatory diseases, allergic diseases, autoimmune diseases, transplant rejection, and similar conditions. The compound is represented by a specific formula, with detailed descriptions provided in the specification. Another notable patent focuses on 2-oxoquinoline compounds and their pharmaceutical applications, further showcasing Kaya's expertise in developing effective therapeutic agents.

Career Highlights

Tetsudo Kaya is currently associated with Japan Tobacco Inc., where he continues to innovate and contribute to the pharmaceutical industry. His work has garnered attention for its potential to address significant health challenges through novel compounds.

Collaborations

Kaya has collaborated with esteemed colleagues, including Takashi Inaba and Hiroyuki Iwamura. These partnerships have facilitated the advancement of research and development in the pharmaceutical sector.

Conclusion

Tetsudo Kaya's contributions to pharmaceutical innovations highlight his role as a key inventor in the industry. His patents reflect a commitment to improving health outcomes through scientific advancements.

Profile summary based on public USPTO records.